Clinical Trials on HER2-positive Carcinoma in Norway
Total 445 results
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
University Hospital, AkershusVestre Viken Hospital Trust; NovartisRecruitingBreast Cancer | Locally Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Luminal A Breast Cancer | Luminal B Breast CancerNorway
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
Oslo University HospitalHologic, Inc.; Cancer Registry of NorwayUnknownRecall Rate | Cancer Detection Rate | False Positive Rate | Positive Predictive ValueNorway
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
National Cancer Institute (NCI)Southwest Oncology GroupCompletedRecurrent Breast Carcinoma | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Oslo University HospitalRecruitingClear Cell Renal Cell Carcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Melanoma Stage IV | Cutaneous Squamous Cell Carcinoma | MSI-HighNorway
-
Oslo University HospitalBristol-Myers SquibbRecruitingHead and Neck Squamous Cell CarcinomaNorway
-
Trio Medicines Ltd.Norwegian University of Science and TechnologyTerminatedChronic Atrophic Gastritis | Hypergastrinemia | Type I Gastric CarcinoidsNorway
-
Oslo University HospitalThe Research Council of Norway; St. Olavs HospitalActive, not recruitingStage I Breast Cancer | Stage II Breast Cancer | DCIS Grade 3 | LCIS, Lobular Carcinoma in SituNorway
-
Haukeland University HospitalUllevaal University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark and other collaboratorsCompletedNeuroendocrine CarcinomaNorway
-
Anne Margarita Dyrhol RiiseUniversity of Oslo; Haukeland University Hospital; Statens Serum InstitutCompleted
-
Sykehuset i Vestfold HFOslo University Hospital; Helse Sor-Ost; University of Geneva, Switzerland; Car...RecruitingQuality of Life | Small Bowel Cancer | Lymph Node Metastases | Small Bowel Carcinoid Tumor | Tumor MetastasisNorway
-
Oslo University HospitalCompletedRenal Cell Carcinoma | Urothelial Carcinoma | Renal Stone | Renal CystNorway
-
University of TromsoCompleted
-
Norwegian University of Science and TechnologySt. Olavs HospitalTerminatedCarcinoma, Non-small-cell LungNorway
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedCarcinoma, Pancreatic DuctalNorway
-
Oslo University HospitalSorlandet Hospital HF; St. Olavs HospitalCompletedCarcinoma, Non-Small-Cell LungNorway
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Norway
-
Lytix Biopharma ASKael-GemVax Co., Ltd.Completed
-
Oslo University HospitalCompleted
-
Helse FonnaCompletedCervical Intraepithelial NeoplasiaNorway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Bayer; United States Department of Defense; Canadian...TerminatedNode Positive HER2 Negative Breast CancerUnited States, Canada, Puerto Rico, Guam
-
PhotocureCompletedCervical Intraepithelial NeoplasiaNorway, Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast CarcinomaUnited States, Puerto Rico
-
Oslo University HospitalSt. Olavs HospitalRecruiting
-
PfizerRecruitingNon-Small Cell Lung CancerNorway
-
Oslo University HospitalTerminatedNon-small Cell Lung CancerNorway
-
Ultimovacs ASAOslo University HospitalActive, not recruitingA Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer. (UV1-hTERT2012L)Non-small Cell Lung CancerNorway
-
Oslo University HospitalRecruitingIntrahepatic CholangiocarcinomaNorway
-
Oslo University HospitalEnrolling by invitation
-
Oncoinvent ASActive, not recruitingPeritoneal Carcinoma | Colorectal CarcinomaNorway, Sweden
-
Oslo University HospitalRecruitingMetastatic Colorectal Cancer | Cholangiocarcinoma | Pancreas AdenocarcinomaNorway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor... and other conditionsUnited States
-
Norwegian University of Science and TechnologyCompletedCarcinoma, Basal Cell | Porokeratosis, Disseminated Superficial ActinicNorway
-
Vestre Viken Hospital TrustOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsRecruitingOncology | NSCLC Stage IV | NSCLC, Stage IIINorway
-
Oslo University HospitalThe Research Council of NorwayRecruitingMesothelioma | Pseudomyxoma Peritonei | Colorectal Carcinoma | Ovarian CarcinomaNorway
-
Herlev HospitalCelgeneCompletedUnresectable Pancreatic CarcinomaDenmark, Norway
-
University of TromsoCompletedPeriodontal Diseases | Streptococcal Infections | Dental Plaque | Sialorrhea | Dental Calculus | Lactobacillus InfectionNorway
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
Oslo University HospitalRecruitingIntrahepatic Cholangiocarcinoma | Chemotherapy EffectNorway
-
Oslo University HospitalUniversity Hospital, AkershusCompletedCervical Cancer | Cervical Intraepithelial Neoplasia | Oropharyngeal CancerNorway
-
Haukeland University HospitalCompleted
-
PhotocureCompletedCervical DysplasiaGermany, Norway
-
Oslo University HospitalUniversity of OsloTerminated
-
Oslo University HospitalBristol-Myers Squibb; Helse Stavanger HF; Sorlandet Hospital HF; Cliniques universitaires... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive TumorNorway, Belgium